These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19755944)

  • 1. Autoimmunity in bullous pemphigoid.
    Wong MM; Giudice GJ; Fairley JA
    G Ital Dermatol Venereol; 2009 Aug; 144(4):411-21. PubMed ID: 19755944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgE autoantibodies in bullous pemphigoid: supporting role, or leading player?
    Ujiie H
    J Dermatol Sci; 2015 Apr; 78(1):5-10. PubMed ID: 25797172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury.
    Fang H; Zhang Y; Li N; Wang G; Liu Z
    Front Immunol; 2018; 9():407. PubMed ID: 29545809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
    Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
    J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathophysiology of bullous pemphigoid.
    Kasperkiewicz M; Zillikens D
    Clin Rev Allergy Immunol; 2007 Oct; 33(1-2):67-77. PubMed ID: 18094948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
    Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
    J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of BP230 autoantibodies in bullous pemphigoid.
    Shih YC; Wang B; Yuan H; Zheng J; Pan M
    J Dermatol; 2020 Apr; 47(4):317-326. PubMed ID: 32048350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.
    Liu Z; Sui W; Zhao M; Li Z; Li N; Thresher R; Giudice GJ; Fairley JA; Sitaru C; Zillikens D; Ning G; Marinkovich MP; Diaz LA
    J Autoimmun; 2008 Dec; 31(4):331-8. PubMed ID: 18922680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.
    van Beek N; Schulze FS; Zillikens D; Schmidt E
    Expert Rev Clin Immunol; 2016; 12(3):267-77. PubMed ID: 26588556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG/IgE bullous pemphigoid with CD45 lymphocytic reactivity to dermal blood vessels, nerves and eccrine sweat glands.
    Abreu-Velez AM; Smith JG; Howard MS
    N Am J Med Sci; 2010 Nov; 2(11):540-3. PubMed ID: 22558563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score.
    Holtsche MM; Goletz S; van Beek N; Zillikens D; Benoit S; Harman K; Walton S; English J; Sticherling M; Chapman A; Levell NJ; Groves R; Williams HC; König IR; Schmidt E;
    Br J Dermatol; 2018 Oct; 179(4):918-924. PubMed ID: 29607480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
    Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bullous pemphigoid (BP) patients with selective IgG autoreactivity against BP230: Review of a rare but valuable cohort with impact on the comprehension of the pathogenesis of BP.
    Ramcke T; Vicari E; Bolduan V; Enk A; Hadaschik E
    J Dermatol Sci; 2022 Feb; 105(2):72-79. PubMed ID: 34930674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain.
    Giudice GJ; Emery DJ; Zelickson BD; Anhalt GJ; Liu Z; Diaz LA
    J Immunol; 1993 Nov; 151(10):5742-50. PubMed ID: 8228259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New aspects on the pathogenesis of bullous pemphigoid].
    Schmidt E; Bröcker EB; Zillikens D
    Hautarzt; 2000 Sep; 51(9):637-45. PubMed ID: 11057389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
    Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
    Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid.
    Messingham KA; Holahan HM; Fairley JA
    Immunol Res; 2014 Aug; 59(1-3):273-8. PubMed ID: 24845463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.
    Nishie W
    J Dermatol Sci; 2014 Mar; 73(3):179-86. PubMed ID: 24434029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring mechanisms of IgE-mediated autoimmunity through the lens of bullous pemphigoid.
    Messingham KN; Randall G; Fairley J
    G Ital Dermatol Venereol; 2016 Apr; 151(2):186-97. PubMed ID: 26959553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.